Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma

NCT05105100 · clinicaltrials.gov ↗
COMPLETED
Status
25
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of California, San Francisco

Collaborators